Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment. (6th September 2018)

• Record Type: Journal Article
• Authors: Gentile, Massimo; Shanafelt, Tait D.; Mauro, Francesca Romana; Reda, Gianluigi; Rossi, Davide; Laurenti, Luca; Del Principe, Maria Ilaria; Cutrona, Giovanna; Angeletti, Ilaria; Coscia, Marta; Herishanu, Yair; Chiarenza, Annalisa; Molica, Stefano; Ciolli, Stefania; Goldschmidt, Neta; Angrilli, Francesco; Giordano, Annamaria; Rago, Angela; Bairey, Osnat; Tripepi, Giovanni; Chaffee, Kari G.; Sameer, Parikh A.; Vigna, Ernesto; Zirlik, Katja; Shvidel, Lev; Innocenti, Idanna; Recchia, Anna Grazia; Di Raimondo, Francesco; Del Poeta, Giovanni; Cortelezzi, Agostino; Neri, Antonino; Ferrarini, Manlio; Gaidano, Gianluca; Kay, Neil E.; Polliack, Aaron; Foà, Robin; Morabito, Fortunato;
• Is Part Of: European journal of haematology. Volume 101:Number 5(2018)
• Page Start: 703
• Page End: 706
• Publication Date: 2018-09-06
• Subjects: chemo‐immunotherapy -- chronic lymphocytic leukemia -- CLL‐IPI -- PFS -- prognosis -- progression‐free survival; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; Blood -- Periodicals; 616.15005
• DOI: 10.1111/ejh.13149
• Languages: English
• ISSNs: 0902-4441